Literature DB >> 412416

The fetal trimethadione syndrome: report of an additional family and further delineation of this syndrome.

G L Feldman, D D Weaver, E W Lovrien.   

Abstract

We describe a family in which seven pregnancies resulted in four infants who died and in three abortions. During these pregnancies the mother took trimethadione (Tridione), as well as other anticonvulsants. Two normal children were born after treatment with all medications were stopped. There have now been 53 reported pregnancies in which the fetuses were exposed to trimethadione or paramethadione; 48 (87%) resulted in fetal loss or a child born with congenital malformations. The most common defects include malformed ears, cleft palate, cardiac defects, urogenital malformations, and skeletal abnormalities. Delayed mental and physical development were also seen. These findings constitute a clinical entity termed the fetal trimethadione syndrome. The malformation rate is believed to be due to the teratogenic effects of trimethadione. Physicians need to be aware of the danger of trimethadione and related drugs during pregnancy and should withhold these medications during this period.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412416     DOI: 10.1001/archpedi.1977.02120250071012

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  8 in total

1.  Fetal environment and congenital malformations.

Authors:  D N Singh
Journal:  Indian J Pediatr       Date:  1989 Sep-Oct       Impact factor: 1.967

Review 2.  Environmental teratogens.

Authors:  R L Brent; D A Beckman
Journal:  Bull N Y Acad Med       Date:  1990 Mar-Apr

3.  Teratogenic risks of antiepileptic drugs.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-22

4.  Epilepsy and pregnancy.

Authors: 
Journal:  Br Med J       Date:  1980-10-25

5.  Anticonvulsant drugs in monotherapy. Effect on the fetus.

Authors:  R Bertollini; B Källen; P Mastroiacovo; E Robert
Journal:  Eur J Epidemiol       Date:  1987-06       Impact factor: 8.082

Review 6.  Risk-benefit assessment of anticonvulsants in women of child-bearing potential.

Authors:  P G Cleland
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 7.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

8.  Hydrogel-Mediated Release of TRPV1 Modulators to Fine Tune Osteoclastogenesis.

Authors:  Ranabir Chakraborty; Tusar Kanta Acharya; Nikhil Tiwari; Rakesh Kumar Majhi; Satish Kumar; Luna Goswami; Chandan Goswami
Journal:  ACS Omega       Date:  2022-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.